| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41686a979f961bce6a9855b4b409a5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
1987-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdd8c756cc90bf450c9dea712151e4cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df29bdad2d16730b6f567510971ff7d |
| publicationDate |
1988-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0257962-A2 |
| titleOfInvention |
Method for treatment of peripheral blood to improve lymphokine activated killer immunotherapy |
| abstract |
A method for treatment of peripheral blood to improve the lymphokine activated killer cell (LAK) phenomenon. In the method, a sample of human peripheral blood is treated to recover a viable subpopulation of white blood cells consisting substantially of natural killer cells. The subpopulation of natural killer cells is incubated in the presence of a lymphokine to cause activation of the natural killer cells. The activated natural killer cells can then be used in adoptive immunotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9101369-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6805861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010118979-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905657-A1 |
| priorityDate |
1986-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |